Belgija - njemački - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orion corporation - budesonid - pulver zur inhalation - 400 µg - budesonid 400 µg/dose - budesonide

Belgija - njemački - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orion corporation - budesonid - pulver zur inhalation - 200 µg - budesonid 200 µg/dose - budesonide

Belgija - njemački - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ferring - budesonid - retardtablette - 9 mg - budesonid 9 mg - budesonide

Belgija - njemački - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mylan epd - budesonid - pulver zur inhalation - 200 µg - budesonid 200 µg/dose - budesonide

Belgija - njemački - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mylan epd - budesonid - pulver zur inhalation - 400 µg - budesonid 400 µg/dose - budesonide

Njemačka - njemački - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ferring gmbh (3076475) - budesonid - retardtablette - teil 1 - retardtablette; budesonid (18667) 9 milligramm

Europska Unija - njemački - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - medikamente für obstruktive atemwegserkrankungen, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).